Although most studies have shown that high CCL5 correlates with poor outcomes in breast cancer [80], correlative studies have also shown a positive association between CCL5 and tumor-infiltrating lymphocytes (TILs) in TNBC. The gene discussed is CCL5; the disease is breast carcinoma.